Related Experiment Video
Updated: May 15, 2026

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria
Published on: February 23, 2014
Streptococcus pseudopneumoniae: an emerging respiratory tract pathogen
J Sariya Mohammadi1, B Dhanashree
1Department of Microbiology, Kasturba Medical College, Manipal University, Mangalore, India.
Background & Objectives:
Streptococcus pseudopneumoniae a member of the Viridans Streptococci, is known to be associated with chronic obstructive pulmonary disease and respiratory tract infections (RTI). Very scanty information is available on the isolation of S. pseudopneumoniae from India. Hence, the present study was an attempt to isolate S. pseudopneumoniae from clinical samples and to study their drug resistance pattern.
Methods:
Sputum samples (n=150) submitted to the microbiology laboratory for routine culture from patients clinically suspected to have lower respiratory tract infection were inoculated onto sheep blood agar and chocolate agar plates. Alpha haemolytic colonies were identified as S. pseudopneumoniae based on absence of capsule, bile solubility and optochin susceptibility in 5 per cent CO₂ and ambient air. Disk diffusion method was used for antibiotic susceptibilily testing.
Results:
Among the samples screened, 4 per cent showed the growth of only S. pseudopneumoniae. Other pathogens isolated were Streptococcus pneumoniae, Moraxella catarrhalis, Klebsiella spp., Enterococcus spp., Pseudomonas spp., Haemophilus influenzae, Staphylococcus aureus, Candida albicans. All the S. pseudopneumoniae isolates were resistant to erythromycin.
Interpretation & Conclusions:
Our preliminary results showed presence of S. pseudopneumoniae in this part of the country and these were associated with RTI. Currently, most clinical laboratories report optochin susceptible isolates in 5 per cent CO₂ as S. pneumoniae and the resistant ones are not further tested for susceptibility in ambient air. As a result, S. pseudopneumoniae may be missed out. Hence, performance of at least two tests, viz. optochin susceptibility with incubation in 5 per cent CO₂ and ambient air along with bile solubility is necessary to differentiate S. pneumoniae from S. pseudopneumoniae.
Insights
Streptococcus pseudopneumoniae was identified in Indian respiratory tract infection samples and showed erythromycin resistance. Accurate identification requires specific tests to differentiate it from Streptococcus pneumoniae.
Area of Science:
- Medical Microbiology
- Bacteriology
- Infectious Diseases
Background:
- Streptococcus pseudopneumoniae, a Viridans Streptococci member, is linked to chronic obstructive pulmonary disease and respiratory tract infections (RTI).
- Limited data exists on S. pseudopneumoniae isolation in India.
Purpose of the Study:
- To isolate S. pseudopneumoniae from clinical samples in India.
- To determine the drug resistance patterns of S. pseudopneumoniae isolates.
Main Methods:
- Sputum samples (n=150) from patients with suspected lower respiratory tract infections were cultured.
- Identification of S. pseudopneumoniae involved assessing capsule absence, bile solubility, and optochin susceptibility under specific atmospheric conditions.
- Antibiotic susceptibility testing was performed using the disk diffusion method.
Main Results:
- S. pseudopneumoniae was isolated from 4% of the screened samples.
- All S. pseudopneumoniae isolates exhibited resistance to erythromycin.
- Other co-isolated pathogens included Streptococcus pneumoniae, Moraxella catarrhalis, and Klebsiella spp.
Conclusions:
- S. pseudopneumoniae is present in India and associated with RTIs.
- Standard laboratory methods may misidentify S. pseudopneumoniae as S. pneumoniae.
- Accurate differentiation requires optochin susceptibility testing in both 5% CO₂ and ambient air, along with bile solubility tests.
Related Concept Videos
Pneumonia I: Introduction
Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Microbiota of the Respiratory Tract
Atypical Pneumonia
Pneumonia II: Pathophysiology
Pneumonia V: Nursing management and Prevention
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed.

